While the majority of the biotech industry focuses on developing new modalities, ORIC Pharmaceuticals, Inc. ( ORIC ) has taken a different path; they have focused on developing small molecule inhibitors that represent the best in classI have a strong inclination towards high-growth companies, often treading in sectors poised for exponential expansion. My expertise lies in understanding and investing in disruptive technologies and forward-thinking enterprises. My approach is a mix of fundamental analysis and ...